LUNA-EMG to Enhance Motor Functions in Multiple Sclerosis
LUNA-EMG to Enhance Lower Limb Motor Functions in Multiple Sclerosis
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 2 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- LUNA-EMG
What it measured
Main measures
Muscle strength in mV
12 weeks
Physical function
Other measures (3)
Timed 25-Foot Walk, seconds
12 weeks
Disability progressionWalking and mobilityTimed Up and Go, seconds
12 weeks
Walking and mobilityProprioception
12 weeks
Who could take part
MS (type not specified) · 18 to 70
Show the full criteria
Inclusion criteria
* EDSS less or equal to 6.5 * Between 18 and 70 years old * Having signed the informed consent
Exclusion criteria
* Acute pain syndrome * Severe cognitive deficits * Risk of fracture or unconsolidated fracture * Rigid joints (spasticity, severe osteoarthritis and arthritis) or unstable joints * Severe ataxia and apraxia * Epilepsy * Pacemakers and similar implants * Insufficient skin conditions
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The aim of the present study is to evaluate the effects of training performed with the LUNA-EMG system to enhance motor functions of the lower limb in multiple sclerosis. This is a randomized open-label trial. Patients will be randomized into the intervention group (LUNA-EMG, 30-45 minutes once a week for 12 weeks) or in the control group (standard care). The effect of the training will be measured based on the muscular strength, walking tests, proprioception and a quality of life questionnaire.
Loading reviews and guidelines…
History
Started
Mar 2021
Main results due
Jun 2024
Finished
Jun 2024